/
Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system.
Mentions
2 mentions · latest on 3 Sept 2026
See which tracked investors hold Kymera Therapeutics, Inc. →Ownership and position changes on OwnershipTrace